It is better to light a candle ... than to repeat the opinions of experts

American Journal of Respiratory and Critical Care Medicine

Volumn 182, Issue 7, 2010, Pages 865-866

  Griffith, David E ^a   Stout, Jason E ^b  

^a Baylor UT Houston Center for AIDS Research   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ISOLATE; BRONCHIECTASIS; BRONCHOSCOPY; CLINICAL ASSESSMENT; DISEASE SURVEILLANCE; EDITORIAL; HEALTH CARE DELIVERY; HEALTH SURVEY; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LABORATORY TEST; LUNG DISEASE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; FEMALE; INCIDENCE; MALE; METHODOLOGY; MYCOBACTERIOSIS; NOTE; UNITED STATES;

FEMALE; HUMANS; INCIDENCE; LUNG DISEASES; MALE; MYCOBACTERIUM INFECTIONS; POPULATION SURVEILLANCE; PREVALENCE; UNITED STATES;

EID: 77958163400     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201008-1251ED     Document Type: Editorial

References (8)

1. Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, Olivier KN. Nontuberculous mycobacterial lung disease prevalence at four integrated healthcare delivery systems. Am J Respir Crit Care Med 2010;182:970-976.
2. Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M, Saulson A, Hedberg K. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med 2010;182:977-982.
3. Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in ontario, 1997 2003. Thorax 2007;62:661-666.
4. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416.
5. Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis 2009;49:e124-e129.
6. Andrejak C, Thomsen VO, Johansen IS, Riis A, Benfield TL, Duhaut P, Sorensen HT, Lescure FX, Thomsen RW. Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med 2010;181:514-521.
7. O'Brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the united states. Results from a national survey. Am Rev Respir Dis 1987;135:1007-1014.
8. van Ingen J, Bendien SA, de Lange WC, Hoefsloot W, Dekhuijzen PN, Boeree MJ, van Soolingen D. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax 2009;64:502-506.